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Abstract
The dynamin-related GTPase protein OPA1, localized in the intermembrane space and tethered to the inner membrane of
mitochondria, participates in the fusion of these organelles. Its mutation is the most prevalent cause of Autosomal
Dominant Optic Atrophy. OPA1 controls the diameter of the junctions between the boundary part of the inner membrane
and the membrane of cristae and reduces the diffusibility of cytochrome c through these junctions. We postulated that if
significant Ca
2+ uptake into the matrix occurs from the lumen of the cristae, reduced expression of OPA1 would increase the
access of Ca
2+ to the transporters in the crista membrane and thus would enhance Ca
2+ uptake. In intact H295R
adrenocortical and HeLa cells cytosolic Ca
2+ signals evoked with K
+ and histamine, respectively, were transferred into the
mitochondria. The rate and amplitude of mitochondrial [Ca
2+] rise (followed with confocal laser scanning microscopy and
FRET measurements with fluorescent wide-field microscopy) were increased after knockdown of OPA1, as compared with
cells transfected with control RNA or mitofusin1 siRNA. Ca
2+ uptake was enhanced despite reduced mitochondrial
membrane potential. In permeabilized cells the rate of Ca
2+ uptake by depolarized mitochondria was also increased in




+ antiporters in this transport process is indicated by
pharmacological data. Altogether, our observations reveal the significance of OPA1 in the control of mitochondrial Ca
2+
metabolism.
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Introduction
Recent observations obtained in imaging and electron tomo-
graphic studies revealed a dynamically changing structure [1,2]
and led to a revised concept of the structure and function of
mitochondria. The changes in the number and size of mitochon-
dria involve alterations in the inner mitochondrial membrane
(IMM). The invaginations of the IMM, termed cristae, display
various conformations under changing energetic conditions. The
cristae are connected to the inner boundary membrane (i.e. the
part of IMM between two neighboring cristae) by narrow tubular
junctions which have a diameter of 15–40 nm [3–6]. These
junctions may impede free diffusion and thus may induce the
formation of a gradient of ions, molecules and macromolecules
between the intermembrane space (IMS) and the lumen of the
cristae [5,7].
The fusion of mitochondria is regulated by the transmembrane
GTPase proteins mitofusin (Mfn) 1 and 2 and OPA1 [1]. Mutation
of the OPA1 gene is the most prevalent cause of the type 1
Autosomal Dominant Optic Atrophy [8,9]. Although the funda-
mental pathology is the degeneration of retinal ganglion cells with
subsequent atrophy of the optic nerve [1,10,11], the protein is
expressed in all examined human tissues, explaining the accidental
association of blindness with external ophthalmoplegia and various
neuromuscular lesions [12–14]. Reduced expression of OPA1 was
also reported in ischaemic heart failure [15] showing that
insufficient expression of the protein may have far-reaching
consequences.
OPA1 (and Mgm1, its ortholog in the yeast) is a dynamin-
related GTPase protein. Due to alternative splicing, its gene is
transcribed into 8 mRNA isoforms [16]. The protein is tethered to
the IMM [17–19] and localized in the IMS [18,20]. In Western
blot analysis 5 separate bands (designated a to e) of molecular
weight, ranging from 94 to 86 kDa, can be found. Two long
isoforms are anchored to the IMM and three soluble short forms
are located in the IMS. These latter bands are the proteolytic
products of the long forms [21,22]. Heteromultimeric complex
formation of Opa1 was suggested on the basis of the relatively
constant stoichiometry of the long and short isoforms [23]. On
their own long and short isoforms have little impact on the fusion
of mitochondria, but when coexpressed they functionally comple-
ment one another [24].
OPA1 regulates the diameter of the crista junction. The tightness
of junctions correlates with the oligomerization of the membrane-
bound and the soluble forms in the IMS [25]. Knockdown of either
the Mfn1 [26–28] or the OPA1 gene brings about the fragmentation
of the mitochondria [19,29,30], moreover, knocking down of OPA1
(or Mgm1) gene also evokes drastic desorganisation of the cristae
[29,31–34]. An essential component of the structural change is the
dilation of the junctions [4] (but see [6]). It has been proposed
several years ago that the size of the junction may modify the
diffusion of molecules like adenine nucleotides [3].
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metabolism has been suggested by numerous observations. The
majority of cytochrome c reductase, F1F0 ATPase [35] and of
cytochrome c oxidase [36], as well as the uncoupling protein 1 (in
brown adipocytes) [37] are found within the crista membrane.
Only 10–15% of cytochrome c is found free in the IMS, while the
major fraction can be found in the cristae [4,38]. The
proapoptotic agent truncated Bid (t-Bid) known to evoke
disassembly of OPA1 oligomers [6,25] brought about a drastic
increase in the junction diameter [4]. This increase was associated
with enhanced cytochrome c release from digitonin-permeabilized
mitochondria [4,6]. The effect of t-Bid could be potentiated with
silencing of OPA1 gene [33] and overcome with overexpression of
OPA1 [25], indicating that the clearance of the junction is
controlled by OPA1. These observations strongly suggest that the
state of OPA1 may modify substrate-dependent enzymatic and
transport processes occuring in the crista membrane.
Calcium mobilising agonists generate cytosolic Ca
2+ signal that
is rapidly transferred into the mitochondrial matrix. This
sequestration of Ca
2+ shapes the cytosolic Ca
2+ signal and thereby
modifies all the Ca
2+ transport processes. The mitochondrial Ca
2+
signal enhances the reduction of mitochondrial pyridine nucleo-
tides and thus potentiates ATP formation (reviewed e.g. in [39])
and hormone secretion [40]. Out of various mechanisms
responsible for Ca
2+ transport from the IMS into the mitochon-
drial matrix (reviewed in [41–43]) the most important one is the
ruthenium red-sensitive mitochondrial Ca
2+ uniporter (MCU), the
driving force of the transport is the mitochondrial membrane
potential (, 180 mV, inside negative) (reviewed in [41]). Patch-
clamp studies revealed that the uniporter is an inwardly rectifying
cation channel [44,45] and a 40 kDa membrane protein has
recently been shown to exhibit the conductive function [46,47]. (A
recently characterized protein, MiCu1 seems to be its Ca
2+-
sensing subunit [48]). The electrogenic mitochondrial Na
+/Ca
2+
antiporter was also reported to transport Ca
2+ into the
mitochondria [49,50]. Similarly, the electrogenic Ca
2+/H
+ anti-
porter, identified as Letm1 [51] may also be responsible for Ca
2+
uptake by depolarized mitochondria. In spite of the progress in the
elucidation of the structure and function of the transporters there
are no data available on their location within the IMM. The only
available exception is the demonstration of mitochondrial Na
+/
Ca
2+ exchanger (NCLX) in the crista membrane with immunoe-
lectron microscopy [52]. Nevertheless, schematic drawings in
several recently published reviews locate the transporters in the
boundary membrane and no Ca
2+ transport is indicated within the
cristae [42,43,53–56]. Here we report that the expression of OPA1
modifies mitochondrial Ca
2+ uptake, suggesting the significance of
the crista membrane in Ca
2+ uptake. Our results imply that OPA1




Mitochondrial morphology in OPA1 siRNA-transfected
cells
In order to evaluate the effect of OPA1 on mitochondrial Ca
2+
uptake we depressed its expression with siRNA. Since silencing of
OPA1 has been known to evoke fragmentation of the mitochondria
(see Introduction) and the ensuing increase in surface/volume
ratio might accelerate the increase in [Ca
2+]m, a group of cells was
treated with Mfn1 siRNA with the intention of evoking similar
mitochondrial fragmentation. Western blot analysis confirmed the
specificity of the OPA1 siRNA on the expression of OPA1
(Figure 1). (The moderate reduction of protein expression in
H295R cells may be accounted for by the poor transfectability of
this cell line.) To test whether Mfn1-silenced cells are more
appropriate controls for OPA1-silenced cells than those transfected
with control (non-silencing) RNA, the morphology of mitochon-
dria was compared in the three groups. As shown in Figures S1
and S2 for H295R and HeLa cells, the filamentous mitochondrial
pattern in cells exposed to control RNA changed into fragmented,
round-shaped mitochondia in OPA1 and Mfn1-silenced cells. In
H295R cells the median value of the length of single mitochondria
diminished from 2.30 mm in control RNA-treated cells to 1.08 and
0.98 mm in cells exposed to Mfn1 and OPA1 siRNA, respectively
(Figure S3). In HeLa cells the median lenght changed from 2.73 to
0.40 and 0.24 mm, respectively (Figure S3). Another conventional
indicator of fragmentation, the circularity (for a circle its value is 1)
increased from a median of 0.199 to 0.447 and 0.452 in H295R
cells and from 0.217 to 0.743 and 0.803 in HeLa cells (Figure S3).
The comparable values obtained in OPA1 and Mfn1 siRNA-
treated cells show that the latter one is an appropriate control for
studying the effect of OPA1 on Ca
2+ metabolism.
Effect of OPA1 silencing on mitochondrial Ca
2+ uptake in
intact cells
For monitoring cytosolic Ca
2+ responses the fluorescent dye
Fura-2 or Fura-FF was used. For following changes in mitochon-
drial [Ca
2+] ([Ca
2+]m) in intact cells the FRET-based, mitochon-
drially targeted, Cameleon-derived fluorescent protein 4mt-D1-
cpV [57] or 4mt-D2-cpV [58], also targeted into the mitochon-
dria, was applied. Their Kd for Ca
2+ was about 10 mM and
85 nM, respectively. (Using null-point titration we measured
pH,8.0 in the mitochondria of resting HeLa and H295R cells,
therefore the Kd values were determined at pH 8.0. ). The FRET
ratio of the fluorescent proteins was insensitive to pH in the 7.6–
8.2 range (data not shown). Fura-2 and 4mt-D2-cpV proved to be
the appropriate sensors in H295R cells whereas Fura-FF and 4mt-
D1-pcV were applied in HeLa cells.
In intact H295R cells we examined the transfer of cytosolic
Ca
2+ signal, elicited with 25 mM K
+, into the mitochondrial
matrix. Whereas the cytosolic signals were almost identical in the
Mfn1 and OPA1 siRNA-treated cells, the FRET ratio of 4mt-D2-
pcV, reflecting [Ca
2+]m, showed a significant increase in the latter
Figure 1. Effect of OPA1 and Mfn1 siRNA on the expression of
OPA1. The cells were transfected with OPA1 siRNA, Mfn1 siRNA or a
non-silencing RNA on the day following plating (day 2). The samples
were lysed on day 5, run on SDS-PAGE, transferred onto nitrocellulose
membrane, incubated with anti-OPA1 mouse monoclonal antibody
then with anti-mouse immunoglobulin-horseradish-peroxidase conju-
gate. Protein disulphide isomerase was used as loading control.
doi:10.1371/journal.pone.0025199.g001
OPA1 and Mitochondrial Ca
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2+
response (D[Ca
2+]m) was related to peak [Ca
2+]c, the normalized
mitochondrial response was again significantly higher in the OPA1-
silenced cells (p=0.0015). The rate of mitochondrial Ca
2+ uptake
(indicated by the slope of the FRET ratio increase) showed a
considerable variance, however, when it was analyzed in function
of [Ca
2+]c, it was found to be significantly higher in the OPA1-
silenced than in the Mfn1-silenced cells (p=0.039) (Figure 2). (No
detectable mitochondrial Ca
2+ signal followed the cytosolic signal
in a few cells, these values have been omitted from this statistics.)
Intact HeLa cells were stimulated with histamine (1, 5 or
50 mM). While transfection with various RNAs did not influence
the cytosolic Ca
2+ response, OPA1 siRNA enhanced the increase in
[Ca
2+]m as compared with either the control RNA or the Mfn1
siRNA-treated group. However, surprisingly, this effect was
detectable only in cases of higher cytosolic response (Figure 3).
When statistics was confined to the populations showing an R/Ro




2+]c peak and the slope of [Ca
2+]m increase normalized to
peak [Ca
2+]c were all significantly greater in OPA1-silenced than in
Mfn1-silenced cells (p= 0.0001, 0.0002, and 0.0024, resp.)
(Figure 4).
Mitochondrial membrane potential after gene silencing
Enhanced mitochondrial Ca
2+ uptake can be attributed to
increased mitochondrial membrane potential (Ym), increased activity
of the Ca
2+ transporting system as well as enhanced access of Ca
2+ to
the transporter. Assessment of Ym with tetramethyl rhodamine
methylester (TMRM) in H295R cells revealed that mitochondria
were depolarized in OPA1 siRNA-transfected cells as opposed to the
effect of Mfn1 siRNA (p=5610
27, Figure S4), a change attenuating
rather than enhancing Ca
2+ uptake. OPA1 siRNA reduced Ym
examined with tetramethyl rhodamine ethylester (TMRE) also in
HeLa cells (p=0.0001). The reduction of Ym has been confirmed
with JC-1 (5,59,6,69-tetrachloro-1,19,3,39- tetraethyl-benzimidazolyl-
carbocyanine iodide) (p=0.0001, Figure S4).
Effect of OPA1 silencing on mitochondrial Ca
2+ uptake in
permeabilized cells
In order to exclude extramitochondrial sites of OPA1 action
and mostly to ensure identical driving force in each experimental
group we next examined the effect of gene silencing in digitonin-
permeabilized cells. The cells had been transfected with
mitochondrially targeted inverse Pericam (mt-inv-Pericam). Its
high Ca
2+ affinity (Kd=0.2 mM at pH 7.4 [59] and ,80 nM at
pH 8.0; not shown) rendered it an appropriate sensor for
measuring initial Ca
2+ uptake rate but no data could be obtained
for the amplitude of the Ca
2+ response. Following the permeabi-
lization the cells were depolarized with a Ca
2+-free cytosol-like
medium lacking mitochondrial substrates but completed with
10 mM rotenon, 8 mg/ml oligomycin, 10 mM FCCP and 50 ng/ml
valinomycin for 2 minutes. To induce mitochondrial Ca
2+ uptake
[Ca
2+] in the superfusion medium was raised from 0 to 5 mM, still
in the presence of the drugs. In OPA1 silenced H295R cells Ca
2+
uptake rate increased by a mean 30% (p=0.034) as compared
with the effect of control RNA and amounted nearly to the double
of that measured in Mfn1 silenced cells (p=0.010, Figure 5).
Applying the same protocol in HeLa cells, no difference in Ca
2+
uptake rate was detected when [Ca
2+]c was raised to 2 mM but
upon adding 5 mMC a
2+ a mean 55% increase in uptake rate was
observed in OPA1-silenced cells as compared with the effect of
Mfn1 silencing (p= 0.00008). Moreover, OPA1-knockdown
augmented Ca
2+ uptake rate when compared to control RNA
treatment (p=0.00008, Figure 6). The 2-min depolarizing
treatment did not change the immunoblot pattern of OPA1
(Figure 6).
Pharmacological characterization of the Ca
2+ transport
mechanism in depolarized mitochondria
Mitochondrial Ca
2+ uptake by MCU (in polarized mitochon-
dria) and by the H
+/Ca
2+ antiporter (Letm1) is inhibited by
Ruthenium Red. In permeabilized, OPA1-silenced H295R cells
the drug (15 mM) strongly inhibited Ca
2+ uptake rate (p=
0.00016). CGP-37157 (25 mM), an inhibitor of the mitochondrial
Na
+/Ca
2+ exchanger exerted a similar effect (p=0.00016). No
inhibition was observed with cyclosporin A (10 mM), an inhibitor
of the mitochondrial permeability transition pore (mPTP) (Figure
S5 panel A and Table S1). Ruthenium Red reduced Ca
2+ uptake
rate to one fifth of the control (p=0.00001) in permeabilized
HeLa cells transfected with OPA1 siRNA. CGP-37157 and
cyclosporin A failed to exert any effect on Ca
2+ uptake (Figure
S5 Panel B and Table S1).
Discussion
Mitochondrial Ca
2+ accumulation occurs predominantly
through the recently identified MCU protein [46,47], an
inwardly rectifying Ca
2+ channel [44]. The uniporter does not
function in depolarized mitochondria [60], under such conditions
the mitochondrial Na
+/Ca
2+ exchanger (NCLX) and/or the
Ca
2+/H
+ exchanger (Letm1) may be responsible for mitochon-
drial Ca
2+ accumulation [49,51,61,62]. An electronmicroscopic
study detected the Na
+/Ca
2+ exchanger predominantly in the
crista membrane [52] but no information is available for the
localization of MCU or Letm1 within the IMM. The major
purpose of the present study was to elucidate whether Ca
2+
uptake occurs exclusively on the inner boundary membrane as
suggested in the schemes of several recently published reviews (see
Introduction) or it also takes place in the crista membrane
[4,6,33]. Recalling that OPA1-knockdown increases the diffus-
ibility of cytochrome c through the crista junctions [4,6,33] we
presumed that if Ca
2+ is sequestered through the crista
membrane, in OPA1-silenced cells the transport should be
enhanced.
In accordance with previous reports [19,29,30] silencing of
OPA1 induced fragmentation of mitochondria. It had to be
considered that the fragmentation results in increased surface/
volume ratio that in turn may lead to amplified increases in
[Ca
2+]m. Therefore cells transfected with Mfn1 siRNA, also
displaying mitochondrial fragmentation [26–28], rather than
control RNA-treated cells were regarded as appropriate con-
trol.Significantly, shortening and circularity of mitochondria were
comparable in the OPA1 and Mfn1 silenced groups.
In K
+-stimulated H295R cells mitochondrial Ca
2+ uptake was
enhanced by OPA1 knockdown as compared to control RNA or
Mfn1 siRNA-transfected cells. Stimulation of HeLa cells with
histamine elicited cytosolic Ca
2+ signal which was rapidly
transferred into the mitochondrial matrix. Whereas OPA1 siRNA
had no obvious effect on the generation of mitochondrial Ca
2+
signal in cells showing low cytosolic Ca
2+ response, significantly
bigger mitochondrial Ca
2+ response and Ca
2+ uptake rate were
attained after OPA1 knockdown in cells showing high cytosolic
response. We presume that at higher Ca
2+ load the access of Ca
2+
to those transporters that are localized in the crista membrane
becomes the rate-limiting factor of the transport. Confirming
previous reports [11,24,63], knockdown of OPA1 but not that of
Mfn1 resulted in mitochondrial depolarization implying that in
OPA1 silenced cells Ca
2+ uptake rate increased in spite of smaller
OPA1 and Mitochondrial Ca
2+ Signaling
PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e25199Figure 2. Effect of OPA1 or Mfn1 silencing on Ca
2+ signaling in intact H295R cells. The cells were transfected with control RNA or siRNA and
4mt-D2-cpV on the day following plating (day 2)and once again with control RNA or siRNA on day 3. On day 5, after preloading with Fura-2 AM, the
cells were stimulated with 25 mM K
+. Changes in cytosolic [Ca
2+] ([Ca
2+]c) were monitored by measuring Fura-2 excitation ratio while [Ca
2+]m was
indicated by the FRET ratio of 4mt-D2-cpV. Both ratios are normalized to those obtained in the control period. Representative cytosolic Ca
2+ signals
(A) and mitochondrial Ca
2+ uptake curves (B) are shown for cells transfected with control RNA, Mfn1 or OPA1 siRNA. C: peak [Ca
2+]c, D: peak [Ca
2+]m
E: [Ca
2+]m response normalized to peak [Ca
2+]c (D[Ca
2+]m/[Ca
2+]c) indicating mitochondrial responsiveness; F: the slope of [Ca
2+]m rise related to peak
[Ca
2+]c (cells not displaying a mitochondrial Ca
2+ response were omitted from this statistics). Data are shown for control (C), Mfn1 siRNA (M) or OPA1
siRNA-transfected (O) groups. Results represent mean + SEM, the number of observations is shown within the columns.
doi:10.1371/journal.pone.0025199.g002
OPA1 and Mitochondrial Ca
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mitochondrial Ca
2+ signaling in intact cells.
In order to ensure stable and identical driving force in each
group Ym was dissipated in permeabilized cells. Permeabilization
of control RNA-transfected cells resulted in the formation of
toroids, probably due to a partial dissociation of the mitochondria
from the microtubules [64]. The permeabilization did not cause
any detectable morphological change of the fragmented mito-
chondria in siRNA-transfected cells (not shown). After complete
depolarization [Ca
2+] was raised to 2 or 5 mM, ensuring that the
concentration gradient of Ca
2+ should be the only driving force of
the transport [65]. ATP depletion [66] as well as protonophores
may evoke proteolysis of OPA1 [21,22,67], however, this did not
occur within 2 minutes in the depolarizing medium. Elevation of
[Ca
2+]t o5mM induced an immediate mitochondrial Ca
2+ influx
in permeabilized H295R cells and Ca
2+ uptake rate was
significantly increased after silencing OPA1. Silencing also
augmented mitochondrial Ca
2+ accumulation in permeabilized
HeLa cells exposed to 5 rather than to 2 mMC a
2+. This
phenomenon resembles the observation in intact cell where the
signal transfer was accelerated by OPA1 siRNA only in cells
displaying high cytosolic Ca
2+ signal.
Ca
2+ uptake may have been enhanced in OPA1-silenced cells
due to hyperpolarization, increased expression or higher Ca
2+
affinity of the transporter or increased access of Ca
2+ to the
transporter. OPA1 siRNA reduces Ym and therefore the driving
force of Ca
2+ uptake. (As to the effect of mitochondrial pH, it
should be recalled that the protonophore FCCP was present in all
the experiments on permeabilized cells.) Had the density or affinity
of the transporter increased, enhanced Ca
2+ accumulation could
be expected even in the presence of lower [Ca
2+]c but this was not
the case in HeLa cells. Therefore it can be considered that, when
[Ca
2+]c is high, Ca
2+ supply of the transporters located in the crista
membrane is a limiting factor. Enhanced access of Ca
2+ to these
transporters in OPA1-silenced cells then augments the efficiency of
the Ca
2+ uptake process. Nevertheless, the possibility should be
kept in mind that if ablation of OPA1 evokes the relocation of the
transporter molecules from the crista into the boundary mem-
brane, mitochondrial Ca
2+ metabolism would alter similarly to the
present observations. Unfortunately, this is difficult to prove or
disprove at this stage.
Which transport mechanism is located in the crista membrane?
The predominant mechanism of Ca
2+ uptake in polarized
mitochondria is the MCU [41–43]. The Ca
2+ transporting
capacity of the supposedly electrogenic H
+/Ca
2+ antiporter [51]
as compared to that of MCU, is negligible [68]. The kinetics of
Ca
2+ uptake in our cells argues against any role of the rapid mode of
Ca
2+ uptake [69]. The enhancement of mitochondrial Ca
2+
uptake in intact, OPA1-silenced cells is compatible with the
presence of MCU in the crista membrane.
The transport mechanism was further analyzed in OPA1
siRNA-transfected, permeabilized cells after depolarizing the
mitochondria. MCU is inactive in depolarized mitochondria
[60]. Ca
2+ uptake by depolarized mitochondria in permeabilized
HeLa cells was reduced by Ruthenium Red. The Ca
2+/H
+
exchanger Letm1 is expressed in HeLa cells and is inhibited by
Ruthenium Red [51]. Ca
2+ uptake was not influenced by CGP-
37157, an inhibitor of the Na
+/Ca
2+ antiporter. In the excitable
Figure 3. Effect of OPA1 or Mfn1 knockdown on Ca
2+ signaling in intact HeLa cells. The cells were transfected with control RNA or siRNA
on the day following plating (day 2) and with 4mt-D1-cpV on day 3. On day 5, after preloading with Fura-FF AM, the cells were stimulated with 1, 5 or
50 mM histamine. Changes in [Ca
2+]c were monitored by measuring Fura-FF excitation ratio while [Ca
2+]m was indicated by the FRET ratio of 4mt-D1-
pcV. Both ratios are normalized to the values obtained in the control period. [Ca
2+]m for the pooled data, as indicated by the FRET signal of 4mt-D2-
cpV, is shown in function of [Ca
2+]c. Figure 4 contains statistics for the cells displaying normalized Fura-FF ratios greater than 1.25 (i.e. for the data
shown right to the broken vertical line).
doi:10.1371/journal.pone.0025199.g003
OPA1 and Mitochondrial Ca
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Ca
2+ uptake and CGP-37157 also exerted a strong inhibition [70].





2+ exchanger in H295R cells and the
former one in HeLa cells participate in the enhanced Ca
2+ uptake
after knockdown of OPA1. In this respect it is worthwhile to recall
that both antiporters are present in the adrenal cortex [70].
Cyclosporin A, an inhibitor of mPTP had no effect in either cell
type. Indeed, in lack of contact between the crista and outer
mitochondrial membranes mPTP may not be directly involved in
Ca
2+ uptake through the crista membrane.In a study on murine
retinal ganglion cells, transiently stimulated with K
+, the
subsequently added protonophore induced bigger cytosolic Ca
2+
signals in OPA1-silenced than in control cells [11]. The data which
show the resultant of mitochondrial Ca
2+ release and elimination
of cytosolic Ca
2+ by Ca.ATPases, can be attributed to changes in
mitochondrial Ca
2+ accumulation. However, in lack of appropri-
ate control with fragmented mitochondria, the role of changes in
various transports processes (e.g. rate of mitochondrial depolar-
ization, rate of Ca
2+ pumping) should also be considered. Our
direct measurements of mitochondrial Ca
2+ metabolism not only
demonstrated the increased rate of Ca
2+ uptake in OPA1-silenced
cells but also excluded the role of mitochondrial membrane
potential in this action of the protein and suggested the presence of
Ruthenium Red-sensitive transport mechanisms in the crista
membrane.
Summarizing, the reduction of OPA1 expression results in
enhanced mitochondrial Ca
2+ uptake rate and augments the
mitochondrial Ca
2+ signal. These results unambiguously
demonstrate that OPA1 restrains mitochondrial Ca
2+ uptake.
On the basis of published data we attribute the uptake
attenuating effect of OPA1 to decreased permeation of Ca
2+
through the junction of the cristae. It follows that enhanced
Ca
2+ uptake in the absence of normal OPA1 function may be
an aggravating component of OPA1-related diseases. Therefore




Cell culture and transfection
H295R cells (CRL-2128, ATCC, Manassas, VA) were grown in
DMEM/Ham’s F12 (1:1 v/v) containing 1% ITS
+, 2% UltroSer
G, 100 U/ml penicillin and 100 mg/ml streptomycin. HeLa cells
(CLL-2, ATCC, Manassas, VA) were grown in DMEM containing
10% heat-inactivated FBS, 100 U/ml penicillin and 100 ug/ml
streptomycin. Passage numbers 3–20 were used.
Cells (about 4*10
4 H295R or 10
4 HeLa) were plated onto 24-
mm diameter circular glass coverslips on day 1. For plasmid
transfection we used 1 mgD N A( o r2 mg in case of H295R
transfection with 4mt-D2-cpV) with transfection reagent (2 ml
Lipofectamine 2000 for H295R or 2–3 ml FuGENE-HD for
HeLa cells) in 1.1 ml OPTI-MEM medium. The transfection was
performed on day 2 or 3. For silencing OPA1 a mixture of three
siRNA species (1299003) was applied, for that of Mfn1 the
product 5141600 and for control a non-silencing RNA with
Figure 4. Mitochondrial Ca
2+ signaling in intact, OPA1 or Mfn1 siRNA-treated HeLa cells displaying large [Ca
2+]c peak. (displaying
normalized Fura-FF ratios greater than 1.25), shown in Figure 3 right to the broken vertical line. Representative curves are shown for [Ca
2+]c measured
with Fura-FF (A) and for [Ca
2+]m measured with 4mt-D1-cpV (B) after stimulation with 5 mM histamine in cells transfected with control RNA, Mfn1
siRNA or OPA1 siRNA. Statistics for peak [Ca
2+]c (C), peak [Ca
2+]m (D), D[Ca
2+]m/[Ca
2+]c indicating mitochondrial responsiveness (E) and the slope of
[Ca
2+]m rise related to peak [Ca
2+]c (F) are shown for control (C), Mfn1 siRNA (M) or OPA1 siRNA-transfected (O) groups. Results represent mean + SEM,
the number of observations is shown within the columns.
doi:10.1371/journal.pone.0025199.g004
Figure 5. Mitochondrial Ca
2+ uptake in permeabilized H295R cells transfected with OPA1 or Mfn1 siRNA. The cells were transfected with
control RNA or siRNA on the day following plating (day 2) and with inverse Pericam targetted into the mitochondria (mt-inv-Pericam) on day 2 or 3.
On day 5 the cells were permeabilized, superfused with a cytosol-like medium, Ym was dissipated with 10 mM rotenon, 8 mg/ml oligomycin, 10 mM
FCCP and 50 ng/ml valinomycin for 2 minutes. Then, in the presence of the drugs, [Ca
2+] was raised from 0 to 5 mM. [Ca
2+]m was monitored by means
of confocal microscopy, applying mt-inv-Pericam, the fluorescence of which exhibits inverse correlation with [Ca
2+]. Fluorescence measured at
saturating [Ca
2+]( F min) was subtracted from each fluorescence value. The data were normalized for the control period. Representative mitochondrial
Ca
2+ uptake curves are shown for cells transfected with Mfn1 or OPA1 siRNA (note that decreasing F/F0 values indicate increasing [Ca
2+]m!) (A); effect
of OPA1 siRNA as compared with that of control RNA (B)o rMfn1 siRNA (C) on the slope of initial decrease of normalized mt-inv-Pericam fluorescence
(indicating the slope of initial increase in [Ca
2+]m). Results represent mean + SEM, the number of observations is shown within the columns.
doi:10.1371/journal.pone.0025199.g005
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Invitrogen (Paisley, UK). Transfection took place on day 2,
40 pmol siRNA were added with 1 ml Lipofectamine RNAiMAX
in 1.1 ml OPTI-MEM medium. When RNA was co-transfected
with the plasmid coding for the Ca
2+ sensitive protein, the
protocol for plasmid transfection was applied. In experiments on
intact H295R cells RNA transfection was repeated on day 3. The
transfection reagents were purchased from Invitrogen, with the
exception of FuGENE-HD (Roche, Mannheim, Germany). The




5 cells cultured in 24-mm diameter dishes were suspended
in ice-cold lysis buffer (100 mM NaCl, 30 mM HEPES pH 7.4,
0.2% Triton X-100, 20 mM NaF, 2.5 mM Na-EGTA, 2.5 mM
Na-EDTA, 10 mM benzamidine, 0.075 U/ml Aprotinin, 1:100
Sigma Mammalian Protease Inhibitor Cocktail, 1 mM sodium-
vanadate, 10 mM PMSF). Insoluble fraction was removed with
centrifugation. Protein concentration was measured with
Bradford or BCA assay. The supernatant was completed with
1/3 volume reducing buffer (125 mM TrisCl pH 6.8, 40%
glycerol, 20% mercaptoethanol, 0,02% bromophenolblue,
280 mM SDS). Samples were run on 8% SDS-PAGE and
transferred onto nitrocellulose membrane (pore size: 0.45 mm).
The membrane was incubated with 3% milk powder+0.1%
Tween 20 in PBS to block nonspecific binding sites. Detection
of OPA1 was performed with anti-OPA1 mouse monoclonal
antibody (Cat. No 612606, BD Bioscience, Franklin Lakes, NJ)
followed by incubation with anti-mouse immunoglobulin-
horseradish-peroxidase conjugate (1:2000) (GE Healthcare,
A m e r s h a m ,U K ) .P r o t e i nd i s u l p h i d ei s o m e r a s ew a su s e da s
loading control (anti-PDI antibody: ab2792, Abcam, Cam-
bridge, UK).
Figure 6. Effect of OPA1 or Mfn1 silencing on mitochondrial Ca
2+ uptake in permeabilized HeLa cells. For the transfection protocol and
measurement of fluorescence see legend of Figure 5. On day 5, after the dissipation of Ym (see legend of Figure 5), [Ca
2+] of the superfusion medium
was raised from 0 to 2 or 5 mM. A: mitochondrial response to 5 mMC a
2+. Representative curves are shown for cells transfected with Mfn or OPA1
siRNA (note that decreasing F/F0 values indicating increasing [Ca
2+]m!). B: Western blot shows that 2-min exposure to the depolarizing medium did
not change the pattern of immunoreactive OPA1. P: permeabilisation, D: dissipation of Ym, C: control. The slope of initial increase in [Ca
2+]m in
permeabilized cells superfused with 2 mM (C) or 5 mMC a
2+ (D and E) is shown in cells transfected with control RNA (D), Mfn1 siRNA (C and E) and
OPA1 siRNA (C, D, E). C: control RNA, M: Mfn1 siRNA, O: OPA1 siRNA. Results represent mean + SEM, the number of observations is shown within the
columns.
doi:10.1371/journal.pone.0025199.g006
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The rate of mitochondrial Ca
2+ uptake and mitochondrial
membrane potential were examined with confocal microscopy.
Cells plated onto glass coverslips were placed on the stage of Zeiss
LSM510 confocal laser scanning microscope equipped with a
406/1.3 oil immersion objective (Plan-Neofluar Zeiss). Mt-inv-
Pericam (gifted by Prof. A. Miyawaki, Saitama, Japan) was excited
at 488 nm; emitted light was filtered using BP 500–550 nm
emission filter. Rhod-2 (3 mM for 15 min) was excited at 543 nm;
the emitted light was filtered using LP 560 filter. The optical slice
was 5 mm, image acquisition frequency in the Ca
2+ uptake
experiments was 1-0.2 Hz. The experiments were performed at
room temperature. The solutions were applied with a solenoid
valve-equipped, gravity-driven superfusion system, terminating at
,2 mm from the selected cells. Flow rate was ,1 ml/min.
Fluorescence intensity was normalized to the intensity measured
before stimulation. The initial linear section of the normalized
curves was regarded as rate of Ca
2+ uptake. Uptake rate was
expressed as (DF/F0)/Dt (Rhod-2) or ((DF2Fmin)/(F02Fmin))/Dt
(mt-inv-Pericam) where F/F0 is fluorescence intensity (F) related to
that measured during the control period (F0) and Fmin is the
fluorescence measured at saturating [Ca
2+]c.
Changes in Ym were followed with TMRE or TMRM. Cells
preloaded with the dye were incubated in the presence of 25 nM
dye. TMRE or TMRM was excited at 543 nm, emitted light was
filtered using LP 560 emission filter. Alternatively, Ym was
examined with JC-1 (30-min loading with 1 mMa t3 7 uC followed
by 10-min incubation in the modified Krebs-Ringer solution
without dye). JC-1 was monitored in ‘‘Multi Track’’ mode,
excitation wavelengths of 488 nm and 543 nm were applied,
emitted light was separated with a beam splitter cutting at 545 nm
and emission filters BP 500–550 nm (green) and LP560 nm (red),
resp., were used. The TMRE or TMRM fluorescence intensities
and the ratios of red to green intensities in JC-1 experiments were
normalized with that measured after depolarizing the mitochon-
dria with FCCP.
For the morphological analysis of mitochondria the cells were
transfected with GFP fused with human cytochrome c oxidase VIII
target sequence. The length and circularity ((4p(area)/(perimeter)
2)
of mitochondria were analyzed with ImageJ 1.6.0, as suggested
[71]. (The major steps were as follows: background substraction –
deconvolution – smoothing – substraction of a Mexican hat
convolved duplicate – threshold – scale setting – analysis of
particles.)
FRET measurements with fluorescent wide-field
microscopy
Mitochondrial [Ca
2+] was monitored with the appropriately
targeted Ca
2+ sensitive fluorescent proteins 4mt-D1-cpV (a gift
from Prof. T. Pozzan, Padova, Italy) or 4mt-D2-cpV. In order to
prepare 4mt-D2-cpV we cut out the 4-mt domain from 4mt-D1-
cpV cloned in pcDNA3.1 with HindIII and inserted it in site of the
2-mt domain of 2mt-D2-cpV (a gift from Dr. A.E. Palmer,
Boulder, CO) also cloned in pcDNA3.1.
Fluorescence intensity measurements were performed on an
inverted microscope (Axio Observer D1, Zeiss) equipped with a
4061.4 oil immersion objective (Fluar, Zeiss) and a Cascade II
camera (Photometrics). Excitation wavelengths were set by a
random access monochromator connected to a xenon arc lamp
(DeltaRAM, Photon Technology International). For ratiometric
FRET measurements of mitochondrially targeted D1 or D2-cpV
excitation wavelength of 430 nm was selected along with a Dual-
View emission splitting system (505dcxr, 480/30 and 535/30;
Photometrics) enabling the acquisition of simultaneous donor and
raw FRET emissions. Alternately cytosolic [Ca
2+] was estimated
with Fura-2 or Fura-FF, excited with 340 and 380 nm and using
the above emission splitting system. Images were acquired every
5 seconds with the MetaFluor software (Molecular Devices) and
MetaMorph was used for data analysis. FRET and Fura ratios
were calculated after background subtraction; ratio of raw FRET
acceptor (Venus) and donor (Cerulean) fluorescence or that of
340 nm/380 nm were used, respectively. Ratios were normalized
to the control period (R0). Mitochondrial Ca
2+ uptake rate was
expressed as (DR/R0)/Dt. Measurements were performed at
31uC.
Solutions
Incubation of intact cells was performed in a modified Krebs-
Ringer solution containing 3.6 mM K
+, 1.2 mM Ca
2+, 0.5 mM
Mg
2+, 10 mM Hepes and 2 mM HCO3
2 (pH 7.4). In experi-
ments studying the effect of K
+, NaCl was partly replaced with N-
methyl-d-glucamine or K
+ in order to maintain Na
+ and osmotic
concentrations constant. Permeabilization was carried out in a
cytosol-like medium (117 mM KCl, 6 mM NaCl, 1 mM
KH2PO4, 2 mM Na
+ pyruvate, 2 mM Na
+ succinate (for HeLa)
or 2 mM Na
+ isocitrate (for H295R), 2 mM K
+ADP, 2 mM
EGTA, 10 mM K
+HEPES or 10 mM K
+MOPS) with 25 mg/ml
digitonin at room temperature for 10 minutes. To adjust the
[Ca
2+] and [Mg
2+] of the cytosol-like media, EGTA, HEDTA,
CaCl2, MgCl2 and ADP were used as calculated by the Chelator
software [72]. The [Ca
2+] of the applied solutions was checked
with a Ca
2+ selective electrode (Orion, Cambridge, UK).
Calculated [Mg
2+] was 0.5 mM.
Statistics
Means + S.E.M. are shown. All the experiments were
performed on at least two different cell passages. For estimating
significance of differences, Student’s unpaired t-test (with or
without Welch correction), one-way ANOVA, Tukey’s or unequal
N HSD post hoc tests or Kruskal-Wallis test were used, as
appropriate. Data were analyzed with Statistica 9.
Supporting Information
Figure S1 Morphology of the mitochondria of RNA-
transfected H295R cells. The cells were transfected with
control RNA (A), Mfn1 siRNA (B)o rOPA1 siRNA (C) on the day
following plating (day 2) and with mitochondrially targeted GFP
on day 3. Confocal microscopy was performed on day 4. The
framed areas are shown in the right-hand column; zoom: 46.
Optical slice thickness was 1 mm. Bars, 10 mm.
(TIF)
Figure S2 Morphology of the mitochondria of RNA-
transfected HeLa cells. The cells were transfected with control
RNA (A), Mfn1 siRNA (B)o rOPA1 siRNA (C) on the day
following plating (day 2) and with mitochondrially targeted GFP
on day 3. Confocal microscopy was performed on day 5. The
framed areas are shown in the right-hand column; zoom: 46.
Optical slice thickness was 1 mm. Bars, 10 mm.
(TIF)
Figure S3 Morphometry of the mitochondria of RNA-
transfected cells. For the experimental protocol see the legend
of Figure S1 (H295R) or 2 (HeLa). The histograms show the
length and circularity of mitochondria in H295R cells (A and B,
resp.) and in HeLa cells (C and D, resp.). Analysis was performed
with ImageJ 1.6.0, as suggested [71].
(TIF)
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transfected HeLa cells. Transfection with control RNA, Mfn1
or OPA1 siRNA was performed on the day following plating.
Three days later Ym was estimated applying TMRM in H295R
cells and TMRE or JC-1 in HeLa cells, respectively. TMRM and
TMRE fluorescence or JC-1 ratio (red/green) over the mitochon-
drial region were normalized to that measured after depolarisation
with FCCP. Means + SEM are shown, the number of observations
is shown within the columns.
(TIF)
Figure S5 Pharmacological characterization of the Ca
2+
transport mechanism in depolarized mitochondria.
H295R cells (A) or HeLa cells (B) were transfected with OPA1
siRNA 1 day after plating (day 2). On day 5 the cells were loaded
with Rhod-2 AM, permeabilized and superfused with a cytosol-
like medium. Ym was dissipated (see legend of Figure 5) and then
[Ca
2+] was raised from 0 to 5 mM. Rhod-2 fluorescence data were
evaluated as described in Methods. Fifteen mM Ruthenium Red
(RR), 25 mM CGP-37157 (CG) and 10 mM cyclosporine A (Cy),
added alone or in combination, were present from the beginning
of permeabilization. The means + SEM of the slopes of the initial
increase in normalized Rhod-2 fluorescence are shown. The
number of observations is shown within the columns. For the
significance of differences see Table S1.
(TIF)
Table S1 Significance of differences for the experi-
ments shown in Figure S5. C: control, RR: Ruthenium Red,
CG: CGP-37157, Cy: cyclosporine A.
(DOC)
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